GE HealthCare Technologies Inc.
Ticker: GEHCHealthcareMedical InstrumentsS&P 500The business
GE HealthCare Technologies Inc. (NYSE: GEHC) is a leading global healthcare solutions provider delivering advanced medical technology, pharmaceutical diagnostics, and artificial intelligence-enabled cloud and software solutions. The company serves patients and providers across more than 160 countries with a workforce of approximately 54,000 colleagues, including 9,700 sales professionals and 8,900 field service engineers. GE HealthCare operates manufacturing, assembly, and pharmaceutical production facilities across 44 locations in 17 countries, supported by a network of over 5,000 indirect third-party partners.
The company operates through four reportable segments aligned with its served industries. The Imaging segment encompasses molecular imaging, computed tomography, magnetic resonance, women's health, and X-ray technologies with associated service capabilities and AI-enabled software solutions. The Advanced Visualization Solutions segment focuses on specialized ultrasound and procedural guidance applications across comprehensive care, women's health, cardiovascular and interventional solutions, and surgical innovations. The Patient Care Solutions segment serves multiple patient care needs through monitoring solutions, diagnostic cardiology, maternal infant care, anesthesia, consumables, and digital applications. The Pharmaceutical Diagnostics segment supplies contrast media and radiopharmaceutical imaging agents globally to support radiology and nuclear medicine diagnostics.
GE HealthCare was spun off from General Electric Company on January 3, 2023, establishing itself as an independent publicly traded company. The company employs approximately 11,100 engineers and scientists focused on research and development across hardware, systems, software, and clinical research disciplines. Its comprehensive portfolio addresses the patient care continuum including screening, diagnosis, therapy, and monitoring through integrated hardware, software, and digital technologies.
The company's competitive advantages include its substantial intellectual property portfolio, global scale complemented by local market focus, integrated supply chain design emphasizing resilience and redundancy, and long-standing collaborations with leading healthcare institutions worldwide. GE HealthCare competes with global and regional participants including Siemens Healthineers, Philips Healthcare, United Imaging, Mindray, and Canon, among others. The company's website is www.gehealthcare.com.
- Sector
- Healthcare
- Industry
- Medical Instruments
- HQ
- CHICAGO, IL
- FY end
- 12-31
- CIK
- 1932393
- SIC
- 3844
Ownership
Who holds GE HealthCare Technologies Inc. — across funds, superinvestors and bonds · N-PORT 2026Q2 · 13F 2026-06-30
Top fund holders
| Fund | % of fund | Value |
|---|---|---|
| Dodge & Cox Stock Fund DODGX · Dodge & Cox Funds | 1.30% | $1.54B |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VTI · VANGUARD INDEX FUNDS | 0.04% | $924.50M |
| VANGUARD 500 INDEX FUND VOO · VANGUARD INDEX FUNDS | 0.05% | $754.45M |
| VANGUARD WINDSOR II FUND VWNFX · VANGUARD WINDSOR FUNDS | 1.02% | $660.13M |
| VANGUARD MID-CAP INDEX FUND VO · VANGUARD INDEX FUNDS | 0.28% | $630.90M |
Superinvestors in GE HealthCare Technologies Inc.
Share of each manager's reported 13F portfolio.
Bonds held by funds
Funds report holding 9 issues of GE HealthCare Technologies Inc.'s debt, $2.36B at fund-held market value — what funds hold, not the company's debt outstanding. Weighted-average coupon 5.43%, maturing 2027–2052.
| Issue | Coupon | Matures | Funds | Fund-held |
|---|---|---|---|---|
| GE HealthCare Technologies Inc | 5.650% | 2027-11-15 | 88 | $520.22M |
| GE HealthCare Technologies Inc | 5.905% | 2032-11-22 | 66 | $516.40M |
| GE HealthCare Technologies Inc | 5.860% | 2030-03-15 | 62 | $271.83M |
| GE HealthCare Technologies, Inc. | 4.800% | 2029-08-14 | 101 | $235.88M |
| GE HealthCare Technologies Inc | 5.500% | 2035-06-15 | 62 | $204.02M |
| GE HealthCare Technologies Inc | 4.150% | 2028-12-15 | 97 | $195.20M |
| GE HEALTHCARE | 4.800% | 2031-01-15 | 74 | $165.16M |
| GE HEALTHCARE | 4.950% | 2035-12-15 | 67 | $159.47M |
| GE HealthCare Technologies Inc | 6.377% | 2052-11-22 | 48 | $87.67M |
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Fund ownership is a subset of institutional 13F ownership — the two describe overlapping populations and must not be added together.
Go deeper in your own AI
15 years of statements, narrative and filings — queryable over MCP.
Professionals can also use the built-in AI chat (subscription + your own Anthropic key).
15 years of GE HealthCare Technologies Inc.'s financials
Income statement, balance sheet and cash flow across 15 years, every filing with its disclosures, and each number traceable to the filing it came from — free with an account, no card required.
Sign in free